Clinical trials
Arthritis, Juvenile trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Recruiting | 15 |
| Active, not recruiting | 4 |
| Not yet recruiting | 3 |
| Unknown status | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 7 |
| Hoffmann-La Roche | 6 |
| Swedish Orphan Biovitrum | 5 |
| AbbVie | 4 |
| Eli Lilly and Company | 4 |
| Bristol-Myers Squibb | 3 |
| Istituto Giannina Gaslini | 3 |
| Duke University | 2 |
| IRCCS Burlo Garofolo | 2 |
| Janssen Research & Development, LLC | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arthritis, Juvenile | 54 |
| Arthritis | 7 |
| Macrophage Activation Syndrome | 4 |
| Arthritis, Psoriatic | 3 |
| Still's Disease, Adult-Onset | 3 |
| Colitis, Ulcerative | 2 |
| Crohn Disease | 2 |
| Arthralgia | 1 |
| Behcet Syndrome | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
Trials
Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.